LENZ Therapeutics, Inc.
LENZ$423M
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaSOLANA BEACH
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
LENZ News
Catalyst Timeline
1 upcoming, 1 past
PDUFANext
FDA PDUFA Date LENZ-123 (standard)
Mar 31, 2026Confirmed
For Alzheimer's disease. NDA filing. Extracted from SEC filing: 8-K
SourceDrug Pipeline
No drugs found in this phase.
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply